Multiple Sclerosis Drugs Market size was valued at USD 23.43 billion in 2022 and is poised to grow at a CAGR of 4.0% over the forecast period 2023-29. Multiple Sclerosis Drugs Market: Multiple Sclerosis (MS) is a demyelinating disease that affects spinal cord and brain. Multiple sclerosis damages myelin sheath, material that surrounds and protects nerve cells. This damage blocks or slows down messages between brain and body. The exact cause of the Multiple Sclerosis disease is unknown but it is an autoimmune disease diagnosis.

https://www.precisionbusinessinsights.com/market-reports/global-multiple-sclerosis-drugs-market/